Results 121 to 130 of about 3,595 (167)
Some of the next articles are maybe not open access.
Drugs, 2008
Dalbavancin is a semisynthetic glycopeptide antibacterial agent that is active against Gram-positive bacteria associated with complicated skin and skin structure infections (cSSSIs). It is administered as a two-dose regimen intravenously infused over 30 minutes once weekly.
Vanessa R, Anderson, Gillian M, Keating
+7 more sources
Dalbavancin is a semisynthetic glycopeptide antibacterial agent that is active against Gram-positive bacteria associated with complicated skin and skin structure infections (cSSSIs). It is administered as a two-dose regimen intravenously infused over 30 minutes once weekly.
Vanessa R, Anderson, Gillian M, Keating
+7 more sources
Journal of Antimicrobial Chemotherapy
BACKGROUND Recently, we documented that proactive therapeutic drug monitoring (TDM) allowed the successful individualization of the timing of dalbavancin administration in patients requiring prolonged antibiotic treatment.
Dario Cattaneo +9 more
semanticscholar +1 more source
BACKGROUND Recently, we documented that proactive therapeutic drug monitoring (TDM) allowed the successful individualization of the timing of dalbavancin administration in patients requiring prolonged antibiotic treatment.
Dario Cattaneo +9 more
semanticscholar +1 more source
Dalbavancin for prosthetic joint infections: Empirical treatment.
Infectious Diseases NowOBJECTIVES Bone and joint infections are complex and require a long course of antibiotics. Dalbavancin is a long half-life lipoglycopeptide, only indicated for skin and soft tissue infections. Studies on bone and joint diffusion are promising.
R. Mairesse +10 more
semanticscholar +1 more source